Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit, Options Granted and Outstanding (Details)

v3.19.3.a.u2
Stockholders' Deficit, Options Granted and Outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended
May 06, 2019
Sep. 30, 2019
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Stock Options [Member]          
Outstanding [Roll Forward]          
Number of options, vested during period (in shares)         38,462
Weighted average exercise price [Abstract]          
Weighted average exercise price, granted (in dollars per shares)         $ 6.76
Nonvested, number of shares [Roll Forward]          
Non-vested options, granted (in shares)         38,462
2019 Incentive Award Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Authorized issuance shares of common stock (in shares)   6,000,000 6,000,000 6,000,000  
Percent of common stock outstanding       10.00%  
Outstanding [Roll Forward]          
Number of options, outstanding (in shares)     5,250,000    
Number of options, vested during period (in shares)     743,000    
Number of options, outstanding (in shares) 5,250,000 5,993,000 5,993,000 5,993,000  
Weighted average exercise price [Abstract]          
Weighted average exercise price, outstanding (in dollars per shares)     $ 5.00    
Weighted average exercise price, granted (in dollars per shares)     5.95    
Weighted average exercise price, vested during period (in dollars per share)     5.05    
Weighted average exercise price, outstanding (in dollars per shares) $ 5.00 $ 5.12 $ 5.12 $ 5.12  
Vested options [Abstract]          
Vested options, vested during period (in shares)     2,080,829    
Vested options, outstanding (in shares)   2,080,829 2,080,829 2,080,829  
Vested options, weighted average exercise price (in dollars per share)   $ 5.05 $ 5.05 $ 5.05  
Vested options, weighted average remaining contractual term     9 years 7 months 6 days    
Vested options, aggregate intrinsic value   $ 2 $ 2 $ 2  
Nonvested, number of shares [Roll Forward]          
Non-vested options, outstanding (in shares)     5,250,000    
Non-vested options, granted (in shares)     743,000    
Non-vested options, vested during period (in shares)     (2,080,829)    
Non-vested options, outstanding (in shares) 5,250,000 3,912,171 3,912,171 3,912,171  
Non-vested options, options expected to vest (in shares)     3,907,571    
Non-vested options, weighted average exercise price (in dollars per share)     $ 5.15    
Non-vested options, weighted average remaining contractual term     9 years 7 months 6 days    
Non-vested options, aggregate intrinsic value   $ 74 $ 74 $ 74  
Nonvested, weighted average grant date fair value [Abstract]          
Non-vested options, weighted average grant date fair value, outstanding (in dollars per share)     $ 2.75    
Non-vested options, weighted average grant date fair value, granted (in dollars per share)     2.56    
Non-vested options, weighted average grant date fair value, vested during period (in dollars per shares)     2.75    
Non-vested options, weighted average grant date fair value, outstanding (in dollars per share) $ 2.75 $ 2.73 $ 2.73 $ 2.73  
2019 Incentive Award Plan [Member] | Stock Options [Member]          
Outstanding [Roll Forward]          
Number of options, vested during period (in shares) 743,000        
Vested options [Abstract]          
Vested options, outstanding (in shares)   912,917 912,917 912,917  
Nonvested, number of shares [Roll Forward]          
Non-vested options, granted (in shares) 743,000        
Nonvested, weighted average grant date fair value [Abstract]          
Share-based compensation expense   $ 2,500   $ 6,700  
Dividend yield       0.00%  
Risk-free rate, minimum       1.41%  
Risk-free rate, maximum       2.39%  
Volatility, minimum       55.00%  
Volatility, maximum       60.00%  
2019 Incentive Award Plan [Member] | Stock Options [Member] | Minimum [Member]          
Nonvested, weighted average grant date fair value [Abstract]          
Exercise price (in dollars per share)   $ 3.7 $ 3.7 $ 3.7  
2019 Incentive Award Plan [Member] | Stock Options [Member] | Maximum [Member]          
Nonvested, weighted average grant date fair value [Abstract]          
Exercise price (in dollars per share)   $ 7.5 $ 7.5 $ 7.5